Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Moore

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Investigational New Drugs|June 9, 1999
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group studyW E Samlowski, D Lew, P J Kuebler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinomaD F Moore, R Pazdur, J L Abbruzzese, et al.
Circulation|September 26, 2001
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapyD F Moore, L T Scott, M T Gladwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trialA Jatoi, P D Steen, P J Atherton, et al.
Cancer Research|July 1, 1995
Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancerC E Szarka, G R Pfeiffer, S T Hum, et al.
Gynecologic Oncology|January 15, 1999
13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trialG R Weiss, P Y Liu, D S Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.
The Cancer Journal From Scientific American|August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trialP J Hesketh, J J Crowley, H A Burris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II studyS R Alberts, P M Townley, R M Goldberg, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Investigational New Drugs|June 9, 1999
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group studyW E Samlowski, D Lew, P J Kuebler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinomaD F Moore, R Pazdur, J L Abbruzzese, et al.
Circulation|September 26, 2001
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapyD F Moore, L T Scott, M T Gladwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trialA Jatoi, P D Steen, P J Atherton, et al.
Cancer Research|July 1, 1995
Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancerC E Szarka, G R Pfeiffer, S T Hum, et al.
Gynecologic Oncology|January 15, 1999
13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trialG R Weiss, P Y Liu, D S Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.
The Cancer Journal From Scientific American|August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trialP J Hesketh, J J Crowley, H A Burris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II studyS R Alberts, P M Townley, R M Goldberg, et al.
Pageof 11